- Developed countries such as Japan, the U.K., and the U.S. are likely to witness considerable rise in elderly population in the near future, which is expected to benefit the nebulizer market
- Increase in the number of patients with cystic fibrosis, COPD, and asthma is projected to boost the demand for nebulizers during the forecast period
ALBANY, N.Y., May 5, 2022 /PRNewswire/ — The value of the global nebulizers market was valued at US$ 1 Bn in 2020. The global market is expected to rise at a CAGR of 6.6% during the forecast period, from 2021 to 2028. The global nebulizers market is anticipated to attain the valuation of US$ 1.7 Bn by 2028. Increase in prevalence of respiratory illnesses such as cystic fibrosis, COPD, and asthma is likely to drive the demand for nebulizers around the world. Technological improvements in healthcare products, increase in global number of elderly patients, and profitable position of multinational as well as regional competitors are likely to add to the development of the global nebulizers market.
Changing lifestyles, pollution, and smoking are only a few of reasons leading to the rise in respiratory problems. In order to obtain competitive advantage in the global nebulizers market, firms are likely to speed up product development. On the other hand, loss of drugs during delivery is anticipated to stifle the expansion of the global nebulizers market during the forecast period.
North America is likely to present substantial…
